论文部分内容阅读
经皮冠状动脉内支架植入(CASI)是目前治疗冠状动脉严重狭窄或闭塞病变,改善心肌供血的有效手段。支架内血栓形成(ST)是伴随着CASI开展而引起广泛关注的严重并发症,尽管目前临床已在CASI术前和术后常规应用抗血小板聚集和抗凝药物治疗,但仍未完全杜绝ST的发生。本文报告
Percutaneous coronary stent implantation (CASI) is the treatment of severe coronary artery stenosis or occlusion lesions, improve myocardial blood supply is an effective means. Stent thrombosis (ST) is a serious complication of widespread concern with the development of CASI. Although antiplatelet aggregation and anticoagulant therapy have been routinely used before and after CASI in clinical practice, ST occur. This report